Table 1.
Year | Development event |
---|---|
1990 | First implantations of the MA60AL multipiece Acrysof IOL in Windsor, UK, and New Orleans, LA, USA, on December 14 (surgeons: Packard and Brint, respectively) |
1991–1992 | MA60AL: European Core Study and parallel FDA clinical study |
1994 | Multipiece MA60AL model approvals: CE mark (notified body TUV) and FDA pre-market approval |
1995 |
Development of Acrysof single-piece design Problems with “Acrysert” pack and glistenings lead to product withdrawal in the USA |
1997 | Single-piece clinical studies start |
1999 | Single-piece clinical studies completed |
2000 | Single-piece Acrysof approval and market release |
2001 | New variations of one-piece for smaller incision injection |
2003 | “Yellow” Acrysof Natural available. Multifocal Acrysof ReSTOR launched outside the USA. Trials on Acrysof toric and Wavefront IOLs begin |
2005 | Launch of Acrysof toric and IQ lenses |
2007 | Acrysof Aspheric ReSTOR+ 3.0 launched in Europe |
2010 | Acrysof Aspheric ReSTOR Toric launched in Europe |
2012 | Acrysof Aspheric ReSTOR+ 2.5 launched in Europe |
2013 | Thomes & Callaghan report on improved manufacturing process—improvements to minimize glistenings |
2015 | Acrysof PanOptix launched outside the USA |
2017 | Clareon introduced in Europe |